Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Friedhelm, Raue"'
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212865 (2019)
INTRODUCTION:Liver metastases from neuroendocrine tumors in multiple endocrine neoplasia syndrome are common (75%) and significantly impairs the prognosis. Characterisation of liver lesions in these patients is challenging, as liver metastases are di
Externí odkaz:
https://doaj.org/article/aa2f33283f4b41c0b4fdb6f3fb8145ab
Autor:
Karin Frank-Raue, Friedhelm Raue
Publikováno v:
Deutsches Ärzteblatt international.
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e3582-e3591
Context Long-term data are scarce on large cohorts with sporadic (sMTC) and hereditary medullary thyroid carcinoma (hMTC). Objectives To compare long-term disease-specific survival (DSS) and outcomes between sMTC and hMTC groups. Design Retrospective
Autor:
Karin Frank-Raue, Friedhelm Raue
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 145:1245-1251
Medullary thyroid carcinoma (MTC) is a rare malignancy and compromises only 3 % of all thyroid carcinomas. MTC cells secret calcitonin, which serves as a sensitive tumor marker for screening and follow-up of MTC. Calcitonin screening in patients with
Autor:
Friedhelm Raue, Matthias Kroiss, Theresa Vogel, Julia Wendler, Michael C. Kreissl, Karin Frank-Raue, Christine Spitzweg, Martin Fassnacht
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:e2239-e2246
Context The clinical relevance of bone metastases (BM) in advanced medullary thyroid carcinoma (MTC) is poorly described. Objective The objectives of this work are to describe the prevalence of BM, frequency of skeletal related events (SREs), and imp
Autor:
Viktoria Florentine Koehler, Pia Adam, Carmina Teresa Fuss, Linmiao Jiang, Elke Berg, Karin Frank-Raue, Friedhelm Raue, Eva Hoster, Thomas Knösel, Hans-Ulrich Schildhaus, Thomas Negele, Udo Siebolts, Kerstin Lorenz, Stephanie Allelein, Matthias Schott, Christine Spitzweg, Matthias Kroiss
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3405
Background: RET (rearranged during transfection) variants are the most prevalent oncogenic events in medullary thyroid cancer (MTC). In advanced disease, multi-tyrosine kinase inhibitors (MKIs) cabozantinib and vandetanib are the approved standard tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8ab058b360ab65d2557b6516901540
https://www.ncbi.nlm.nih.gov/pubmed/35884466
https://www.ncbi.nlm.nih.gov/pubmed/35884466
Autor:
Kerstin Lorenz, Burkhard Riemann, Costanza Chiapponi, Alexandra Zahn, Andreas Pfestroff, Andreas Zielke, Henning Dralle, Marcus Quinkler, Sina Schrägle, Anna Nießen, Stefan Kircher, Thomas Steinmüller, Friedhelm Raue, Christian Scheuba, Philipp Riss, Christian Vorländer, Matthias Kroiss, Christina Lenschow, Karl Alexander Iwen, Nicolas Schlegel, Christine Spitzweg, Andreas Machens, Cornelia Dotzenrath
OBJECTIVE In this retrospective cohort study, we describe the clinical presentation and workup of parathyroid carcinoma (PC) and determine its clinical prognostic parameters. Primary outcome was recurrence free survival. SUMMARY BACKGROUND DATA PC is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968f823943142a8905077131fa61070c
https://www.ncbi.nlm.nih.gov/pubmed/32649472
https://www.ncbi.nlm.nih.gov/pubmed/32649472
Autor:
Friedhelm Raue, Karin Frank-Raue
Publikováno v:
Clinics, Vol 67, Pp 69-75 (2012)
Multiple endocrine neoplasia type 2 is an autosomal-dominant hereditary cancer syndrome caused by missense gain-of-function mutations of the rearranged during transfection proto-oncogene, which encodes the receptor tyrosine kinase, on chromosome 10.
Externí odkaz:
https://doaj.org/article/b405be7fd0ad4373be083769eae60447
Autor:
Friedhelm Raue, Karin Frank-Raue
Medullary thyroid carcinoma (MTC) is a rare calcitonin (Ctn)-secreting tumour of the C cells of the thyroid. MTC often have the clinical and histological features of neuroendocrine tumours. They account for 3–5% of all thyroid carcinomas and occur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::250453b7868a1ea3e3d25429a42933a5
https://doi.org/10.1093/med/9780198870197.003.0080
https://doi.org/10.1093/med/9780198870197.003.0080
Autor:
Karin Frank-Raue, Friedhelm Raue
Publikováno v:
Der Onkologe. 25:573-579